A high-performance liquid chromatography-tandem mass spectrometry method for the clinical combination study of carboplatin and anti-tumor agent eribulin mesylate (E7389) in human plasma (Q46331398)
Jump to navigation
Jump to search
scientific article published on 19 September 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A high-performance liquid chromatography-tandem mass spectrometry method for the clinical combination study of carboplatin and anti-tumor agent eribulin mesylate (E7389) in human plasma |
scientific article published on 19 September 2008 |
Statements
1 reference
A high-performance liquid chromatography-tandem mass spectrometry method for the clinical combination study of carboplatin and anti-tumor agent eribulin mesylate (E7389) in human plasma (English)
1 reference
Christopher Desjardins
1 reference
Phil Saxton
1 reference
Sharon X Lu
1 reference
Xiaofang Li
1 reference
Christopher Rowbottom
1 reference
Y Nancy Wong
1 reference
19 September 2008
1 reference
875
1 reference
2
1 reference
373-382
1 reference